103 filings
10-Q
2024 Q1
CTCX
Carmell Corp - Ordinary Shares
Quarterly report
15 May 24
4:21pm
S-1
CTCX
Carmell Corp - Ordinary Shares
IPO registration
10 May 24
4:17pm
D
CTCX
Carmell Corp - Ordinary Shares
30 Apr 24
$3.00 mm in equity, sold $3.00 mm, 19 investors
10:36am
8-K
CTCX
Carmell Corp - Ordinary Shares
4 Apr 24
Carmell Announces $3.0 Million Private Placement
5:28pm
8-K
d9lvhzjb
1 Apr 24
Carmell Announces Successful Closing of Axolotl Biologix Sale Transaction
4:47pm
8-K
yeau6hj1 r5ui0eo
25 Mar 24
Entry into a Material Definitive Agreement
8:46pm
8-K
3gvnechp78 g2
16 Jan 24
Carmell Corp Announces Addition of Dr. Bradley Calobrace to Scientific Advisory Board
7:27pm
8-K
2rimis7n48 cp0
16 Jan 24
Carmell Corp Announces Addition of Dr. Sean Kelishadi to Scientific Advisory Board
7:14pm
8-K
90o 5s3lz
16 Jan 24
Carmell Corp Announces Addition of Dr. Gregory A. Buford to Scientific Advisory Board
7:07pm
8-K/A
j5zb97f s5
16 Jan 24
Carmell Corp Announces Addition of Dr. Adam Rubinstein to Scientific Advisory Board
7:06pm
8-K/A
oc8hk3i5l
16 Jan 24
Carmell Corp Announces Addition of Dr. Jason D. Bloom to Scientific Advisory Board
6:51pm
8-K
g97 sqvefk
16 Jan 24
Carmell Corp Announces Addition of Dr. Adam Rubinstein to Scientific Advisory Board
6:06pm
8-K
lquj19 de
16 Jan 24
Carmell Corp Announces Addition of Dr. Jason D. Bloom to Scientific Advisory Board
6:01pm
8-K
7yp156
5 Jan 24
Departure of Directors or Certain Officers
4:39pm
8-K
30yjnwf7b
15 Nov 23
Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of Directors
9:54pm
NT 10-Q
uodch4m8ay qmf
15 Nov 23
Notice of late quarterly filing
4:56pm
8-K/A
07i gcjxrh
25 Oct 23
Unaudited Condensed Financial Statements
4:02pm